Article
Homozygous FANCM Variant c.5101C>T p.(Gln1701*) in a Patient With Early Onset Breast Cancer, Chemotherapy Toxicity, and Chromosome Fragility: A Case Report.
Cancer reports (Hoboken, N.J.) - 1 Aug 2025
Sulkava Sonja, Hakonen Anna H, Christensen Rikke, Pöyhönen Minna, Nevanlinna Heli
Abstract excerpt
BACKGROUND: Biallelic FANCM variants are linked to a Fanconi anemia-like cancer predisposition syndrome, which includes early onset breast cancer, chemotherapy toxicity, and chromosome fragility. Additionally, heterozygous truncating variants have been linked to increased breast cancer risk. However, the published results have been inconsistent, and the risks and the functional effects associated with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
